Literature DB >> 20821007

Methodological issues in the evaluation of FDG PET/CT accuracy in pediatric lymphoma.

Kevin London, Robert Howman-Giles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20821007     DOI： 10.1007/s00259-010-1594-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  10 in total

1.  F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.

Authors:  Miguel Hernandez-Pampaloni; Amol Takalkar; Jian Q Yu; Hongming Zhuang; Abass Alavi
Journal:  Pediatr Radiol       Date:  2006-04-19

2.  Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Authors:  Malik E Juweid; Sigrid Stroobants; Otto S Hoekstra; Felix M Mottaghy; Markus Dietlein; Ali Guermazi; Gregory A Wiseman; Lale Kostakoglu; Klemens Scheidhauer; Andreas Buck; Ralph Naumann; Karoline Spaepen; Rodney J Hicks; Wolfgang A Weber; Sven N Reske; Markus Schwaiger; Lawrence H Schwartz; Josee M Zijlstra; Barry A Siegel; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

3.  Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease.

Authors:  Edita Kabickova; David Sumerauer; Eliska Cumlivska; Eva Drahokoupilova; Michaela Nekolna; Marketa Chanova; Marie Hladikova; Roman Kodet; Otakar Belohlavek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-25       Impact factor: 9.236

4.  18F-FDG PET in children with lymphomas.

Authors:  Gisele Depas; Caroline De Barsy; Guy Jerusalem; Claire Hoyoux; Marie-Françoise Dresse; Marie-France Fassotte; Nancy Paquet; Jacqueline Foidart; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-24       Impact factor: 9.236

5.  Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?

Authors:  M J Reinhardt; C Herkel; C Altehoefer; J Finke; E Moser
Journal:  Ann Oncol       Date:  2005-06-09       Impact factor: 32.976

6.  Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients.

Authors:  Elka Miller; Ur Metser; Galia Avrahami; Rina Dvir; Dalia Valdman; Liat Ben Sira; Dror Sayar; Yoav Burstein; Amos Toren; Isaac Yaniv; Einat Even-Sapir
Journal:  J Comput Assist Tomogr       Date:  2006 Jul-Aug       Impact factor: 1.826

7.  Role of PET/CT in malignant pediatric lymphoma.

Authors:  Raef Riad; Walid Omar; Magdy Kotb; Magdy Hafez; Iman Sidhom; Manal Zamzam; Iman Zaky; Hussein Abdel-Dayem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-15       Impact factor: 9.236

8.  Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma.

Authors:  Holly J Meany; Vinod K Gidvani; Caterina P Minniti
Journal:  Pediatr Blood Cancer       Date:  2007-04       Impact factor: 3.167

9.  (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging.

Authors:  Egesta Lopci; Roberta Burnelli; Valentina Ambrosini; Cristina Nanni; Paolo Castellucci; Lorenzo Biassoni; Domenico Rubello; Stefano Fanti
Journal:  Cancer Biother Radiopharm       Date:  2008-12       Impact factor: 3.099

10.  [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.

Authors:  F Montravers; D McNamara; J Landman-Parker; D Grahek; K Kerrou; N Younsi; M Wioland; G Leverger; J N Talbot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-25       Impact factor: 9.236
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.